Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
University of Virginia
Turnstone Biologics, Corp.
Kymab Limited
Seagen Inc.
Aminex Therapeutics, Inc.
Astellas Pharma Inc
Molecular Templates, Inc.
Rain Oncology Inc
University of Florida
Fate Therapeutics
Repertoire Immune Medicines
Incyte Corporation
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
CureOne
National Institutes of Health Clinical Center (CC)